BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8975781)

  • 1. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae.
    Sánchez-Fortún S; Barahona MV
    Ecotoxicol Environ Saf; 2009 Mar; 72(3):775-80. PubMed ID: 18191451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.
    Petrikovics I; Hong K; Omburo G; Hu QZ; Pei L; McGuinn WD; Sylvester D; Tamulinas C; Papahadjopoulos D; Jaszberenyi JC; Way JL
    Toxicol Appl Pharmacol; 1999 Apr; 156(1):56-63. PubMed ID: 10101099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central therapeutic effects of dihydroderivative of pralidoxime (pro-2-PAM) in organophosphate intoxication.
    Rump S; Faff J; Borkowska G; Ilczuk I; Rabsztyn T
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):321-32. PubMed ID: 677965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of organophosphate-inactivated esterases with phosphotriesterase.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Fundam Appl Toxicol; 1996 Jun; 31(2):210-7. PubMed ID: 8789787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on the efficacy of PAM against sumithion poisoning].
    Sekita K
    Nihon Hoigaku Zasshi; 1992 Feb; 46(1):14-31. PubMed ID: 1597930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
    Tuovinen K; Hänninen O
    Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride.
    Mittra S; Peshin SS; Lall SB
    Acta Pharmacol Sin; 2001 Jan; 22(1):37-9. PubMed ID: 11730559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
    Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
    Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The activity of blood cholinesterase in rats exposed to dimethypo after drug intervention].
    Wan W; Xu M; Zou H; Lu A; Shen X; Chen Y
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Dec; 20(6):419-21. PubMed ID: 14694588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
    Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
    Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
    Galli A; Mori F
    Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats.
    Kenley RA; Howd RA; Uyeno ET
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1001-8. PubMed ID: 7178195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
    Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
    J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase.
    Pei L; Petrikovics I; Way JL
    Fundam Appl Toxicol; 1995 Dec; 28(2):209-14. PubMed ID: 8835230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats.
    Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.